Evidence map›Paper›PMID 34623065›Full record

ArticleObstetrics and gynecology2021

Evaluation of a Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol.

Michelle Y Lu, Christina T Blanchard, Elizabeth B Ausbeck, Kacie R Oglesby, Margaret R Page, Allison J Lazenby, Gabriella D Cozzi, Rodrigo D Muñoz Rogers, Elisa T Bushman, Elle R Kaplan and 9 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Obstetrics and gynecology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Postpartum pharmacologic thromboprophylaxis and complications in a US cohort.American journal of obstetrics and gynecology · 2024
    Article
  13. Article
  14. Article
  15. Observational
  16. Review
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Michelle Y LuCenter for Women's Reproductive Health, the Department of Obstetrics and Gynecology, and the Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama; Novant Health Maternal-Fetal Medicine, Charlotte, North Carolina; the Department of Otolaryngology, University of Mississippi Medical Center, Jackson, Mississippi; the Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana; the Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina; and the University of Alabama at Birmingham School of Medicine, Birmingham, Birmingham, Alabama.
Christina T Blanchard
Elizabeth B Ausbeck
Kacie R Oglesby
Margaret R Page
Allison J Lazenby
Gabriella D Cozzi
Rodrigo D Muñoz Rogers
Elisa T Bushman
Elle R Kaplan
Martha F Ruzic
Mythreyi Mahalingam
Sarah Dunk
Macie Champion
Brian M Casey
Alan T Tita
Dhong-Jin Kim
Jeff M Szychowski
Akila Subramaniam
University of Alabama at Birmingham · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate outcomes before and after implementation of a risk-stratified heparin-based obstetric thromboprophylaxis protocol.

methodsWe performed a retrospective cohort study of all patients who delivered at our tertiary care center from 2013 to 2018. Deliveries were categorized as preprotocol (2013-2015; no standardized heparin-based thromboprophylaxis) and postprotocol (2016-2018). Patients receiving outpatient anticoagulation for active venous thromboembolism (VTE) or high VTE risk were excluded. Coprimary effectiveness and safety outcomes were postpartum VTEs and wound hematomas, respectively, newly diagnosed after delivery and up to 6 weeks postpartum. Secondary outcomes were other wound or bleeding complications, including unplanned surgical procedures (eg, hysterectomies, wound explorations) and blood transfusions. Outcomes were compared between groups, and adjusted odds ratios (aORs) and 95% CIs were calculated using the preprotocol group as reference.

resultsOf 24,229 deliveries, 11,799 (49%) occurred preprotocol. Although patients were more likely to receive heparin-based prophylaxis postprotocol (15.6% vs 1.2%, P<.001), there was no difference in VTE frequency between groups (0.1% vs 0.1%, odds ratio 1.0, 95% CI 0.5-2.1). However, patients postprotocol experienced significantly more wound hematomas (0.7% vs 0.4%, aOR 2.34, 95% CI 1.54-3.57), unplanned surgical procedures (aOR 1.29, 95% CI 1.06-1.57), and blood transfusions (aOR 1.34, 95% CI 1.16-1.55).

conclusionRisk-stratified heparin-based thromboprophylaxis in a general obstetric population was associated with increased wound and bleeding complications without a complementary decrease in postpartum VTE. Guidelines recommending this strategy should be reconsidered.

Indexed as

Delivery, ObstetricAdultAnticoagulantsBlood TransfusionFemaleHematomaHeparinHumansPostoperative ComplicationsPostpartum HemorrhagePregnancyPregnancy Complications, CardiovascularProgram EvaluationRetrospective StudiesRisk FactorsVenous ThromboembolismAnticoagulantsHeparin

Identifiers

PMID34623065
OpenAlexW3201459570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.